Register information Patent

DE file number : 60 2013 075 341.5 (Status: pending/in force, Query started: May 7, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2013 075 341.5
96EP file numberEAKZ17 17 5885.7
97EP publication numberEPN3444261
54Designation/titleTI2,2-DIFLUORPROPIONAMID-DERIVAT VON BARDOXOLONMETHYL, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND POLYMORPHE DAVON ZUR BEHANDLUNG VON KRANKHEITEN
51IPC main classICM
(ICMV)		 C07J 63/00 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 31/565 (2006.01), A61P 29/00 (2006.01)
22DE application dateDATApr 24, 2013
96EP application dateEATApr 24, 2013
43Date of first publicationOTFeb 20, 2019
Date of publication of grantPETJan 13, 2021
71/73Applicant/ownerINHReata Pharmaceuticals Holdings, LLC, Plano, TX, US
72InventorINANDERSON, Eric, Southlake, TX 76092, US; DECKER, Andrea, 4055 Basel, CH; LIU, Xiaofeng, Coppell, TX 75019, US
74RepresentativeVTRVOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE
Address for service VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261687669 P
Apr 27, 2012
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361775288 P
Mar 8, 2013
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361780444 P
Mar 13, 2013
Due dateFT
FG		Apr 30, 2026
Annual fee for the 14th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003444261A1
Searchable text: EP000003444261A1
Original document: EP000003444261B1
Searchable text: EP000003444261B1
43Date of first publicationEVTFeb 20, 2019
Date of the first transfer into DPMAregisterEREGTFeb 20, 2019
Date of the (most recent) update in DPMAregisterREGTMar 28, 2025
(Show all update days)(Hide all update days)
  • Mar 28, 2025
    • Due date: changed
  • Dec 14, 2024
    • St.36: changed (technical change)
  • May 8, 2024; Mar 26, 2024; Apr 21, 2023; Aug 25, 2022; Jul 20, 2022; Jun 8, 2022; Apr 13, 2022; Jan 5, 2022; Dec 2, 2021; Apr 8, 2021; Feb 9, 2021; Feb 5, 2021; Dec 31, 2020; Dec 30, 2020; Dec 24, 2020; Aug 22, 2019
    • Historical data not available for this/these date(s)
  • Feb 20, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Feb 20, 2019  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Apr 4, 2019 Apr 4, 2019 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 13, 2021  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Feb 4, 2021 Feb 4, 2021 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 14, 2021 Jan 5, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Jul 19, 2022 Aug 25, 2022 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTFeb 20, 2019
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTApr 4, 2019
Issue numberHN14
YearPJ2019
Publication dateVTApr 4, 2019
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 13, 2021
Date of update of the procedureREGTDec 24, 2020
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTFeb 4, 2021
Issue numberHN5
YearPJ2021
Publication dateVTFeb 4, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTFeb 5, 2021
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 14, 2021
Issue numberHN1
YearPJ2022
Publication dateVTJan 5, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJan 5, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 19, 2022
Issue numberHN34
YearPJ2022
Publication dateVTAug 25, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHReata Pharmaceuticals Holdings, LLC, Plano, TX, US
71/73Previous applicant/ownerINHFReata Pharmaceuticals, Inc., Irving, Tex., US
Date of update of the procedureREGTAug 25, 2022